International Clinical Trial: Immunogenicity and Safety of High-dose Influenza Vaccine in People Living With HIV/AIDS and Low CD4 Count

Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (TCTR20250910008) titled 'Immunogenicity and Safety of High-dose Influenza Vaccine in People Living With HIV/AIDS and Low CD4 Count' on Sept. 10.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Faculty of Medicine, Chiang Mai University, Thailand

Condition: Immunogenicity and safety of high-dose influenza vaccine in people living with HIV who has low CD4 count. Influenza, Vaccination, HIV Influenza, Vaccination, HIV

Intervention: Subject will receive intramuscular injection of 60 mcg tetravalent influenza vaccine after 10 mL of blood drawn for baseline.,Subject will receive intramuscular injection of 15 mcg te...